Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreas Cancer-Associated Weight Loss
Andrew Hendifar, Maria Q. B. Petzel, Teresa A. Zimmers, et al.
The Oncologist (2018) Vol. 24, Iss. 5, pp. 691-701
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review
Paolo Bossi, Paolo Delrio, A. Mascheroni, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1980-1980
Open Access | Times Cited: 267
Does Losing Weight Lower the Risk of Cancer: A Systematic Review and Meta-analysis
Nikolaos Tzenios, Mary Tazanios, Omasyarifa Binti Jamal Poh, et al.
(2022)
Open Access | Times Cited: 162
Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia
Joseph E. Rupert, Ashok Narasimhan, Daenique H. A. Jengelley, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 6
Open Access | Times Cited: 135
A tumor-secreted protein utilizes glucagon release to cause host wasting
Guangming Ding, Yingge Li, Cheng Chen, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Sex Differences in Cancer Cachexia
Xiaoling Zhong, Teresa A. Zimmers
Current Osteoporosis Reports (2020) Vol. 18, Iss. 6, pp. 646-654
Open Access | Times Cited: 77
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin
Xiaoling Zhong, Ashok Narasimhan, Libbie M. Silverman, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 4, pp. 2146-2161
Open Access | Times Cited: 58
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Meredith L. Stone, Gregory L. Beatty
Pharmacology & Therapeutics (2019) Vol. 201, pp. 202-213
Open Access | Times Cited: 59
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405
Brendan J. Guercio, Sui Zhang, Fang‐Shu Ou, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 29, pp. 2620-2631
Open Access | Times Cited: 56
Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison
Tamhida Masi, Bhoomika M. Patel
Pharmacological Reports (2020) Vol. 73, Iss. 1, pp. 17-30
Closed Access | Times Cited: 54
Pancreas Cancer-Associated Pain Management
Andrew L. Coveler, Jonathan D. Mizrahi, Bory Eastman, et al.
The Oncologist (2021) Vol. 26, Iss. 6, pp. e971-e982
Open Access | Times Cited: 51
Nutritional Support in Pancreatic Diseases
Pablo Cañamares‐Orbís, Guillermo García‐Rayado, Enrique Alfaro-Almajano
Nutrients (2022) Vol. 14, Iss. 21, pp. 4570-4570
Open Access | Times Cited: 31
Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer
Geert Roeyen, Frederik Berrevoet, Ivan Borbath, et al.
ESMO Open (2022) Vol. 7, Iss. 1, pp. 100386-100386
Open Access | Times Cited: 29
Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer
Nathaniel E. Davis, Jonathan J. Hue, Ravi Kumar Kyasaram, et al.
Psycho-Oncology (2022) Vol. 31, Iss. 8, pp. 1390-1398
Closed Access | Times Cited: 29
Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma – analysis from SWOG S1505
Davendra Sohal, Robert D. Boutin, Leon Lenchik, et al.
Journal of Gastrointestinal Surgery (2024) Vol. 28, Iss. 3, pp. 232-235
Closed Access | Times Cited: 7
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1655-1655
Open Access | Times Cited: 47
Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary Cancer
Jonathan J. Hue, Kavin Sugumar, Ravi Kumar Kyasaram, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 11, pp. 6283-6292
Closed Access | Times Cited: 33
Using deep learning to predict abdominal age from liver and pancreas magnetic resonance images
Alan Le Goallec, Samuel Diai, Sasha Collin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop
José M. Garcia, Richard F. Dunne, Kristen Santiago, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 2, pp. 1418-1425
Open Access | Times Cited: 26
Prognostic values of the prognostic nutritional index, geriatric nutritional risk index, and systemic inflammatory indexes in patients with stage IIB–III cervical cancer receiving radiotherapy
Hongbing Wang, Xintian Xu, Mengxing Tian, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 14
Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study
Lauren K. Park, Kian‐Huat Lim, J. L. Volkman, et al.
Cancer & Metabolism (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
deepPERFECT: Novel Deep Learning CT Synthesis Method for Expeditious Pancreatic Cancer Radiotherapy
Hamed Hooshangnejad, Quan Chen, Xue Feng, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3061-3061
Open Access | Times Cited: 13
Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients
Jodie A. Barkin, Amy Westermann, William Hoos, et al.
Pancreas (2019) Vol. 48, Iss. 6, pp. 780-786
Open Access | Times Cited: 38
Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
Caspar Franck, Christian D. Muller, Rosa Rosania, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1955-1955
Open Access | Times Cited: 35
Nutrition and Pancreatic Cancer
Mary Phillips, Oonagh Griffin
(2021), pp. 548-554
Closed Access | Times Cited: 31
Usefulness of Smartphone Apps for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial
Jiyoung Keum, Moon Jae Chung, Young‐In Kim, et al.
JMIR mhealth and uhealth (2021) Vol. 9, Iss. 8, pp. e21088-e21088
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top